Evidence map›Paper›PMID 37853046›Full record

ArticleCommunications biology2023

Nucleoporin downregulation modulates progenitor differentiation independent of nuclear pore numbers.

Amy E Neely, Yang Zhang, Laura A Blumensaadt, Hongjing Mao, Benjamin Brenner, Cheng Sun, Hao F Zhang, Xiaomin Bao

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Amy E NeelyDepartment of Molecular Biosciences, Northwestern University, Evanston, IL, 60208, USA.
Yang ZhangDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, 60208, USA. yang.zhangfl@gmail.com.ORCID http://orcid.org/0000-0003-1011-3001
Laura A BlumensaadtDepartment of Molecular Biosciences, Northwestern University, Evanston, IL, 60208, USA.
Hongjing MaoMolecular Analytics and Photonics (MAP) Lab, Department of Textile Engineering, Chemistry and Science, North Carolina State University, Raleigh, NC, 27606, USA.
Benjamin BrennerDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, 60208, USA.
Cheng SunDepartment of Mechanical Engineering, Northwestern University, Evanston, IL, 60208, USA.ORCID http://orcid.org/0000-0002-2744-0896
Hao F ZhangDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, 60208, USA.ORCID http://orcid.org/0000-0001-5089-1196
Xiaomin BaoDepartment of Molecular Biosciences, Northwestern University, Evanston, IL, 60208, USA. xiaomin.bao@northwestern.edu.ORCID http://orcid.org/0000-0002-8845-5012
Northwestern University · USNorth Carolina State University · US

Funding

Technology Development UnitU54CA268084 · NCI · NORTHWESTERN UNIVERSITY · PI Vadim Backman, Daniela E Matei · 2022 to 2026
$10.0M
Epidermal Gene Regulation by Transcription Elongation and TerminationR01AR075015 · NIAMS · NORTHWESTERN UNIVERSITY · PI BAO, XIAOMIN · 2020 to 2024
$1.7M
Photoactivatable Fluorophores for High-Throughput Multiplexed Tracking of Single-Molecules in Live CellsR01GM143397 · NIGMS · UNIVERSITY OF MIAMI CORAL GABLES · PI RAYMO, FRANCISCO M · 2022 to 2025
$1.4M
Intrinsic-contrast super-resolution imaging of DNA at 2-nm resolutionR01GM139151 · NIGMS · NORTHWESTERN UNIVERSITY · PI ZHANG, HAO F · 2020 to 2023
$1.3M
Development of spectroscopic Single-Molecule Localization MicroscopyR01GM140478 · NIGMS · NORTHWESTERN UNIVERSITY · PI SUN, CHENG, ZHANG, HAO F · 2021 to 2024
$1.2M
Bright and switchable fluorophores for highly multiplexed super-resolution microscopy towards molecular interaction imagingR21GM141675 · NIGMS · NORTHWESTERN UNIVERSITY · PI ZHANG, YANG · 2021 to 2022
$400k
NCI NIH HHS U54 CA268084NIAMS NIH HHS R01 AR075015NIGMS NIH HHS R01 GM139151NIGMS NIH HHS R01 GM140478NIGMS NIH HHS R01 GM143397NIGMS NIH HHS R21 GM141675
6 · The paper itself

Abstract

Nucleoporins (NUPs) comprise nuclear pore complexes, gateways for nucleocytoplasmic transport. As primary human keratinocytes switch from the progenitor state towards differentiation, most NUPs are strongly downregulated, with NUP93 being the most downregulated NUP in this process. To determine if this NUP downregulation is accompanied by a reduction in nuclear pore numbers, we leveraged Stochastic Optical Reconstruction Microscopy. No significant changes in nuclear pore numbers were detected using three independent NUP antibodies; however, NUP reduction in other subcellular compartments such as the cytoplasm was identified. To investigate how NUP reduction influences keratinocyte differentiation, we knocked down NUP93 in keratinocytes in the progenitor-state culture condition. NUP93 knockdown diminished keratinocytes' clonogenicity and epidermal regenerative capacity, without drastically affecting nuclear pore numbers or permeability. Using transcriptome profiling, we identified that NUP93 knockdown induces differentiation genes related to both mechanical and immune barrier functions, including the activation of known NF-κB target genes. Consistently, keratinocytes with NUP93 knockdown exhibited increased nuclear localization of the NF-κB p65/p50 transcription factors, and increased NF-κB reporter activity. Taken together, these findings highlight the gene regulatory roles contributed by differential NUP expression levels in keratinocyte differentiation, independent of nuclear pore numbers.

Indexed as

Nuclear PoreNuclear Pore Complex ProteinsActive Transport, Cell NucleusDown-RegulationHumansNF-kappa BNF-kappa BNuclear Pore Complex Proteins

Identifiers

PMID37853046
PMCPMC10584948
OpenAlexW4387742540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.